Results 21 to 30 of about 553,624 (295)

SENSITIVITY AND SPECIFICITY OF RISK MALIGNANCY INDEX (RMI) AND RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) FOR THE DIFFERENTIATION OF OVARIAN NEOPLASMS AT THE PREOPERATIVE STAGE

open access: yesВ мире научных открытий, 2016
In Russia, the “profile” of patients with ovarian neoplasms defines the gynecologist, who must still at the preoperative stage most reliably assess the probability of malignancy for the correct selection of further tactics of the treatment.
Mariya Alekseevna Egunova   +1 more
doaj   +1 more source

Bilateral malignant ovarian tumor: a rare combination of mixed epithelial tumor - serous adenocarcinoma with Brenner’s and pure Brenner’s tumor [PDF]

open access: yesNew Indian Journal of OBGYN, 2023
Mixed epithelial ovarian tumors, by definition are composed of admixtures of two or more of the five major cell types: serous, mucinous, endometroid, clear cell and Brenner/ transitional.
Sonia H, Bhavya HU , Geeta J Doppa
doaj   +1 more source

Accuracy of intraoperative frozen section in the diagnosis of ovarian neoplasms: Experience at a tertiary oncology center

open access: yesWorld Journal of Surgical Oncology, 2006
Background Epithelial ovarian neoplasms are an important cause of morbidity and mortality in women. The surgical management of ovarian neoplasms depends on their correct categorization as benign, borderline or malignant.
Goyal Lt Col   +5 more
doaj   +1 more source

Ovarian thecoma presenting with acute ovarian torsion in pregnancy; report of a rare case

open access: yesClinical Case Reports, 2022
Thecoma is a commonly benign ovarian tumor of the group “Sex cord‐stromal neoplasms.” This group represents
Asieh Maleki   +2 more
doaj   +1 more source

Immuno-reactivity of Engrailed (EN)-2 in Epithelial Ovarian Neoplasms [PDF]

open access: yesResearch in Oncology
Background: Ovarian neoplasm refers to any tumor that originates primarily in the ovary. Epithelial ovarian neoplasms are the most common type of ovarian tumor and are classified based on their histogenetic and immunophenotypic features.
Noha Hassab El-Naby   +4 more
doaj   +1 more source

Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications [PDF]

open access: yes, 2011
Recent studies have shown aberrant expression of SOX11 in various types of aggressive B-cell neoplasms. To elucidate the molecular mechanisms leading to such deregulation, we performed a comprehensive SOX11 gene expression and epigenetic study in stem ...
Amador Virginia   +107 more
core   +1 more source

Apatone® induces endometrioid ovarian carcinoma (MDAH 2774) cells to undergo karyolysis and cell death by autoschizis: A potent and safe anticancer treatment [PDF]

open access: yes, 2015
Ovarian cancers are still the most lethal gynecologic malignancy. As a novel strategy against this poor outcome cytotoxic alterations induced by a pro-oxidant treatment on human ovarian endometrioid carcinoma (MDAH 2774) cells are revisited by using ...
Gilloteaux, Jacques   +12 more
core   +1 more source

Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma

open access: yesFrontiers in Endocrinology, 2021
BackgroundNeuroendocrine neoplasms are a heterogeneous group of cancers that develop from enterochromaffin cells of the diffuse endocrine system, with an increase in incidents over the last years.
Marta Opalińska   +5 more
doaj   +1 more source

Microsatellite instability in ovarian neoplasms [PDF]

open access: yesBritish Journal of Cancer, 1995
Microsatellite instability has been observed in a variety of sporadic malignancies, but its existence in sporadic ovarian cancer has been the subject of conflicting reports. We have performed a polymerase chain reaction-based microsatellite analysis of DNAs extracted from the neoplastic and non-neoplastic tissues of 41 ovarian cancer patients.
King, B. L.   +6 more
openaire   +3 more sources

Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors [PDF]

open access: yes, 2009
Background: The aim of this study was to assess the prognostic value of cancer antigen (CA) 125 and CA 72-4 in patients with ovarian borderline tumor (BOT).
Linda Hertlein   +17 more
core   +2 more sources

Home - About - Disclaimer - Privacy